View Phoreus’ revolutionary new transfection reagent offering. Comprised of BAPC™ branched amphipathic peptide capsules, an entirely new class of nanocarrier, this offering overcomes many of the common transfection issues associated with lipid and polymer-based products. View multiple transfection reagent offerings below:
“BAPtofect-25 systems have revolutionized our transfection process and allowed our undergraduate researchers to transfect dsRNA within the first week of being in our lab. Amazingly easy and accurate.”
Dr. James Balthazor Assistant Professor, Department of Chemistry“There was no difference in siRNA knockdown of a target protein in CHO cells following transfection with BAPC vs. two other transfection agents (TransIt-X2 and Lipofectamine 3000). In addition, we found that the presence of BAPC did not affect cell viability after one month of cryopreservation. We have plans to expand these comparisons to additional cell lines in the near future.”
Dr. Barry Bradford Professor, Animal Sciences and Industry“This technology will enable future medical and therapeutic tools. It carries infinite possibilities.”
Dr. Yoonseong Park Professor, Department of Entomology“The addition of BAPC improves delivery of CRISPR components, plasmids, and dsRNA for heritable gene editing and gene targeting in insect nymphs and adults. The first heritable gene Knockouts, using BAPC-assisted-CRISPR-Cas9, produced G2 mutants from injected adult females.”
The FASEB Journal, Abstract Number: 626.2
